← All decks

Cardiology

Advances and Challenges in Iodinated Contrast Media

Built from Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease

What’s inside

9 sections · 99 slides

  1. 01

    Overview

    • Scope of this presentation

    1 slide

  2. 02

    Evolution and classification of iodinated contrast media

    • Role of iodinated contrast media in imaging
    • Osmolality as the defining parameter
    • Evolution of contrast agents
    • Ionic high-osmolality contrast media
    • Low-osmolality contrast media
    • Iso-osmolar contrast media
    • Viscosity of contrast agents
    • Dosing limits and hydration
    • Iohexol, a nonionic low-osmolar agent
    • Iodixanol, an iso-osmolar agent
    • Selective coronary angiogram
    • Contrast-enhanced cardiac computed tomography, short axis
    • Volume-rendered cardiac computed tomography
    • Nephrotoxicity across agent classes
    • Iodixanol versus iohexol in diabetic renal impairment
    • Haemodynamic and electrophysiologic effects
    • Contribution of contrast to catheterisation complications
    • Current utilisation and the cost debate

    18 slides

  3. 03

    Hypersensitivity reactions to iodinated contrast media

    • Mechanism of anaphylactoid reactions
    • The shellfish and iodine allergy misconception
    • Incidence of acute allergy-like reactions
    • Multicentre study of 196,081 patients
    • Recurrence risk after a previous reaction
    • Urticarial wheals
    • Severity-tailored premedication
    • Premedication regimen before elective procedures
    • Changing the agent after a reaction
    • Intradermal skin testing to select an alternative
    • Prevention strategy for a patient with prior reaction
    • Risk of severe reaction with asthma and beta-blockade
    • Delayed hypersensitivity reactions
    • Iotrolan and delayed reactions

    14 slides

  4. 04

    Contrast-induced thyroid dysfunction

    • The acute Wolff–Chaikoff effect
    • Escape from the acute Wolff–Chaikoff effect
    • Two outcomes of iodine excess
    • Jöd–Basedow phenomenon
    • Incidence and risk of contrast-induced hyperthyroidism
    • Diagnosis and management of contrast-induced hyperthyroidism
    • Contrast-induced hypothyroidism
    • Management and monitoring of thyroid dysfunction

    8 slides

  5. 05

    Thrombogenic effects of iodinated contrast media

    • Contrast media and haemostasis
    • Platelet effects of ionic versus nonionic agents
    • Effects on coagulation and fibrinolysis
    • Endothelial injury from contrast media
    • Contrast type and thrombus during angioplasty
    • Ionic contrast and stent occlusion
    • Contradictory prospective data on thrombotic events
    • Limitations of the early comparative trials
    • Ionic versus nonionic contrast: the balance

    9 slides

  6. 06

    Contrast-induced nephropathy

    • Definition of contrast-induced nephropathy
    • Clinical course of contrast-induced nephropathy
    • Incidence of contrast-induced nephropathy
    • Nonmodifiable risk factors
    • Modifiable risk factors
    • Contrast volume and anaemia as predictors
    • Risk factors for contrast-induced nephropathy
    • Assessing renal function before contrast
    • Contrast nephropathy in acute coronary syndrome
    • Long-term impact: HORIZONS-AMI and ACUITY
    • Ischaemic and bleeding events after contrast nephropathy

    11 slides

  7. 07

    Prevention: contrast minimisation and renal protection

    • Core preventive measures
    • Intravenous fluid regimen
    • Dynamic coronary roadmap to reduce contrast volume
    • Dynamic coronary roadmap: subgroups and safety
    • The COURT trial
    • COURT trial: the thrombus signal
    • The ICON trial
    • The VICC and VIP trials
    • The NITRATE-CIN trial
    • NITRATE-CIN: one-year outcomes
    • The PRESERVE trial
    • Interpreting PRESERVE
    • Renin-angiotensin blockade before contrast
    • Choice of contrast agent in high-risk patients
    • Iso-osmolar versus low-osmolar in primary intervention

    15 slides

  8. 08

    Future directions and remaining questions

    • Nanoparticle-based contrast agents
    • Materials used in nanoparticle agents
    • Safety profile of nanoparticle agents
    • Gadolinium as an alternative contrast agent

    4 slides

  9. 09

    Summary

    • Key numbers to remember
    • What is established and what is not
    • Unresolved questions
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease
    • Join our WhatsApp groups

    11 slides